Company Overview
About Frontier Medicines
Frontier Medicines is a South San Francisco-based biopharmaceutical company founded in 2018 by Ulf Bhatt and Jonathan Ogg, with scientific founding involvement from leading chemoproteomics researchers. The company's core focus is developing precision medicines against proteins that have historically been considered "undruggable" — disease-causing targets where conventional drug discovery approaches have failed due to the protein's structure, chemistry, or biology. Frontier addresses this challenge through two proprietary technology platforms: the Frontier platform (chemoproteomics-based covalent chemistry for small molecule drug discovery) and the AutoTAC platform (targeted protein degradation using autophagy pathways).
Business Model & Competitive Advantage
Frontier's chemoproteomics approach uses mass spectrometry-based proteomics to systematically profile reactive cysteines and other functional residues across thousands of proteins simultaneously — identifying novel binding pockets on target proteins that can be engaged by covalent small molecules. This enables the company to design drugs that bind irreversibly to previously inaccessible sites on oncoproteins, opening up targets like mutant KRAS (a driver in ~30% of all cancers), STAT3, and others that have resisted drug discovery efforts for decades. The AutoTAC platform extends this by designing molecules that recruit autophagy machinery to selectively degrade target proteins — a targeted protein degradation approach complementary to the more widely known PROTAC technology.
Competitive Landscape 2025–2026
Frontier Medicines raised over $350M in total funding, including a $257M Series C in 2022 led by Dragoneer Investment Group, with participation from Foresite Capital, GV (Google Ventures), and others. The company's clinical programs span multiple oncology indications targeting KRAS and other precision oncology drivers. Frontier competes in the precision oncology drug discovery space with companies like Revolution Medicines, Relay Therapeutics, and Recursion Pharmaceuticals, as well as Big Pharma oncology R&D divisions pursuing similar undruggable targets.
Key Differentiators
Emerging Innovator
Frontier Medicines is an emerging player bringing innovative solutions to the Life Sciences & BioTech market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
Tempus
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o
Karius
Karius is a Redwood City, CA-based life sciences company founded in 2014 that developed the Karius Test — a single blood draw that uses next-generation sequencing and AI to detect over 1,000 pathogens
ConcertAI
ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult
DNAnexus
DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a
Compare Frontier Medicines with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Frontier Medicines? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Frontier Medicines Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Frontier Medicines vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →